Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response

Addictive Behaviors

Volumn 38, Issue 5, 2013, Pages 2119-2127

  Gueorguieva, Ralitza ^a   Wu, Ran ^b   Krystal, John H ^b,c   Donovan, Dennis ^d   O'Malley, Stephanie S ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acamprosate; Compliance; Medication adherence; Naltrexone; Side effects; Therapy

Indexed keywords

NALTREXONE; PLACEBO;

ADULT; AGE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; CORRELATIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREDICTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84874421357     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.01.024     Document Type: Article

References (50)

1. Anton R.F., Moak D.H., Latham P. The Obsessive Compulsive Drinking Scale: A self rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism, Clinical and Experimental Research 1995, 19:92-99.
2. Anton R.F., Moak D.H., Latham P., Waid L.R., Myrick H., Voronin K., et al. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. Journal of Clinical Psychopharmacology 2005, 25(4):349-357.
3. Anton R.F., O'Malley S.S., Ciraulo D., Cisler R.A., Couper D., Donovan D.M., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: A randomized controlled trial. Journal of the American Medical Association 2006, 295:2003-2017.
4. Azrin N.H., Sisson R.W., Meyers R., Godley M. Alcoholism treatment by disulfiram and community reinforcement therapy. Journal of Behavior Therapy and Experimental Psychiatry 1982, 13(2):105-112.
5. Byrne M.K., Deane F.P. Enhancing patient adherence: Outcomes of medication alliance training on therapeutic alliance, insight, adherence, and psychopathology with mental health patients. International Journal of Mental Health Nursing 2011, 20(4):284-295.
6. Carroll K.M. Enhancing retention in clinical trials of psychosocial treatments: Practical strategies. NIDA research monograph series, monograph no. 165, NIH pub no. 97-4142 1997, 4-24.
7. Chick J., Anton R., Checinski K., Croop R., Drummond D.C., Farmer R., et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism 2000, 35(6):587-593.
8. Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication adherence. Clinical Therapeutics 2001, 23(8):1296-1310.
9. Combine Research Group The Combined Pharmacotherapies and Behavioral Interventions Study (COMBINE) (data files and documentation). Sponsored by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health 2001-2004, DHHS.
10. Connors G.J., Carroll K.M., DiClemente C.C., Longabaugh R., Donovan D.M. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. Journal of Consulting and Clinical Psychology 1997, 65:588-598.
11. DiClemente C.C., Carbonari J.P., Montgomery R.P., Hughes S.O. The Alcohol Abstinence Self-Efficacy scale. Journal of Studies on Alcohol 1994, 55(2):141-148.
12. Dundon W.D., Pettinati H.M., Lynch K.G., Xie H., Varillo K.M., Makadon C., et al. The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence. Drug and Alcohol Dependence 2008, 95:230-236.
13. Ernst D.B., Pettinati H.M., Weiss R.D., Donovan D.M., Longabaugh R. An intervention for treating alcohol dependence: Relating elements of medical management to patient outcomes with implications for primary care. Annals of Family Medicine 2008, 6(5):435-440.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV) 1997, American Psychiatric Press, Washington, DC.
15. Fuertes J.N., Mislowack A., Bennett J., Paul L., Gilbert T.C., Fontan G., et al. The physician-patient working alliance. Patient Education and Counseling 2006, 66:29-36.
16. Fuller R.K., Branchey L., Brightwell D.R., Derman R.M., Emrick C.D., Iber F.L., et al. Disulfiram treatment of alcoholism. Journal of the American Medical Association 1986, 256(11):1449-1455.
17. Hall S.M., Havassy B.E., Wasserman D.A. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. Journal of Consulting and Clinical Psychology 1990, 59:175-181.
18. Heffner J.L., Tran G.Q., Johnson C.S., Barrett S.W., Blom T.J., Thompson R.D., et al. Combining motivational interviewing with compliance enhancement therapy (MI-CET): Development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy. Journal of Studies on Alcohol and Drugs 2010, 71(1):61-70.
19. Heinala P., Alho H., Kiianmaa K., Lonnqvist J., Kuoppasalmi K., Sinclair J.D. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: A factorial double-blind, placebo-controlled trial. Journal of Clinical Pharmacology 2001, 21:287-292.
20. Jones B., Nagin D.S., Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociological Methods and Research 2001, 29:374-393.
21. Kadden R.P., Carroll K., Donovan D., Cooney N., Monti P., Abrams D., et al. Cognitive-behavioral coping skills therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Project MATCH monograph series 1995, Vol. 3. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
22. Krupnick J.L., Sotsky S.M., Simmens S., Moyer J., Elkin I., Watkins J., et al. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology 1996, 64(3):532-539.
23. Krystal J.H., Cramer J.A., Krol W.F., Kirk G.F., Rosenheck R.A. Naltrexone in the treatment of alcohol dependence. The New England Journal of Medicine 2001, 345:1734-1739.
24. Mattson M.E., Del Boca F.K., Carroll K.M., Cooney N.L., DiClemente C.C., Donovan D., et al. Adherence with treatment and follow-up protocols in project MATCH: Predictors and relationship to outcome. Alcoholism, Clinical and Experimental Research 1998, 22(6):1328-1339.
25. McConnaughy E.N., Prochaska J.O., Velicer W.F. Stages of change in psychotherapy: Measurement and sample profiles. Psychotherapy: Theory, Research and Practice 1983, 20:368-375.
26. Meier P.S., Barrowclough C., Donmall M.C. The role of the therapeutic alliance in the treatment of substance misuse: A critical review of the literature. Addiction 2005, 100(3):304-316.
27. Meyers R.J., Smith J.E. Clinical guide to alcohol treatment: The community reinforcement approach 1995, Guilford Press, New York.
28. Miller W.R. Form 90: A structured assessment interview for drinking and related behaviors 1996, Vol. 5. U.S. Department of Health and Human Services, Bethesda, MD.
29. Combined Behavioral Intervention manual: A clinical research guide for therapists treating people with alcohol abuse and dependence 2004, Vol. 1. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
30. Miller W.R., Tonigan J.S., Longabaugh R. Drinker Inventory of Consequences (DrInC): An instrument for assessing adverse consequences of alcohol abuse. Test manual 1995, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
31. Miller W.R., Zweben A., Diclemente C.C., Rychtarik R.G. Motivational enhancement therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence 1992, Vol. 2. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
32. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 1986, 24:67-74.
33. Muthén B.O. Mplus technical appendices 2004, Muthén & Muthén, Los Angeles, CA, (Appendix 8).
34. Nagin D.S. Analyzing developmental trajectories: A semiparametric, group-based approach. Psychological Methods 1999, 4:139-157.
35. Nowinski J., Baker S., Carroll K. Twelve step facilitation therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence 1992, Vol. 1. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
36. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 1992, 49(11):881-887.
37. Osterberg L., Blashke T. Adherence to medication. The New England Journal of Medicine 2005, 353:487-497.
38. Pettinati H.M., Weiss R.D., Miller W.R., Donovan D.M., Ernst D.B., Rounsaville B.J. Medical Management (MM) treatment manual: A clinical research guide for medically trained clinicians providing pharmacotherapy as part of the treatment for alcohol dependence 2004, Vol. 2. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
39. Project MATCH Research Group Therapist effects in three treatments for alcohol problems. Psychotherapy Research 1998, 8:455-474.
40. Reid S.C., Teesson M., Sannibale C., Matsuda M., Haber P.S. The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: A randomized controlled trial. Journal of Studies on Alcohol 2005, 66(6):833-841.
41. Skinner H.A., Allen B.A. Alcohol dependence syndrome: Measurement and validation. Journal of Abnormal Psychology 1982, 91:199-209.
42. Sobell L.C., Sobell M.B. Timeline Follow-back: A technique for assessing self-reported ethanol consumption. Measuring alcohol consumption: Psychosocial and biological methods 1992, Human Press, New Jersey. J. Allen, R.Z. Litten (Eds.).
43. Sobell L.C., Sobell M.B. Alcohol consumption measures. Assessing alcohol problems: A guide for clinician and researchers 1995, 55-73. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD. J.P. Allen, M. Columbus (Eds.).
44. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-AR). British Journal of Addictions 1989, 84:1353-1357.
45. The COMBINE Study Research Group Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: Rationale and methods. Alcoholism, Clinical and Experimental Research 2003, 27:1107-1122.
46. Toll B.A., McKee S.A., Martin J., Jatlow P., O'Malley S.S. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine & Tobacco Research 2007, 9:597-605.
47. Volpicelli J.R., Rhimes K.C., Rhines J.S., Volpicelli L.A., Alterman A.I., O'Brien C.P. Naltrexone and alcohol dependence. Role of subject adherence. Archives of General Psychiatry 1997, 54:737-742.
48. Weiss R.D. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 2004, 99(11):1382-1392.
49. Zeber J.E., Copeland L.A., Good C.B., Fine M.J., Bauer M.S., Kilbourne A.M. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. Journal of Affective Disorders 2008, 107:53-62.
50. Zweben A., Pettinati H.M., Weiss R.D., Youngblood M., Cox C.E., Mattson M.E., et al. Relationship between medication adherence and treatment outcomes: The COMBINE study. Alcoholism, Clinical and Experimental Research 2008, 32(9):1661-1669.